Increased bax/bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with Myasthenia gravis

In Vivo

Volumn 21, Issue 1, 2007, Pages 123-132

  Salakou, Stavroula ^a   Kardamakis, Dimitrios ^a   Tsamandas, Anthanassios C ^a   Zolota, Vassiliki ^a   Apostolakis, Efstratios ^a   Tzelepi, Vassiliki ^a   Papathanasopoulos, Panagiotis ^a   Bonikos, Dionysis S ^a   Papapetropoulos, Theodore ^a   Petsas, Theodore ^a   Dougenis, Dimitrios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Apoptosis; Bax Bcl 2 ratio; Caspase 3; Myasthenia gravis; Prognosis; Thymectomy

Indexed keywords

AZATHIOPRINE; CASPASE 3; MESSENGER RNA; PREDNISONE; PROTEIN BAX; PROTEIN BCL 2; PYRIDOSTIGMINE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; ENZYME ACTIVATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; MALE; MYASTHENIA GRAVIS; NICK END LABELING; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; THYMECTOMY; THYMOMA; THYMUS ATROPHY; THYMUS DISEASE; THYMUS HYPERPLASIA; TREATMENT RESPONSE; TUMOR REGRESSION; UPREGULATION;

EID: 33847668419     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Penn AS and Rowland P: Disorders of the neuromuscular junction. In: Merritt's Textbook of Neurology. Rowland P (ed.). Baltimore, Williams and Wilkins, pp. 754-761, 1995.
2. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE and Taylor WF: Thymoma. A clinicopathologic review. Cancer 60: 2727-2743, 1987.
3. Jaretzki A and Wolff M: Maximal thymectomy for myasthenia gravis. J Thorac Cardiovasc Surg 96: 711-716, 1988.
4. Bulkey GB, Bass KN, Stephenson R, Deiner-West M, George S, Reilly PA, Baker RR and Drachman DB: Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 226: 324-335, 1997.
5. Jaretzki A, Barohn RB, Ernstoff R, Kaminski HR, Keesey JC, Penn AS and Sanders DB: Myasthenia gravis: recommendation for clinical research standards. Ann Thorac Surg 70: 327-334, 2000.
6. Rao L and White E: Bcl-2 and the ICE family of apoptotic regulators: making a connection. Current Opin Genet Dev 7: 52-58, 1997.
7. Cummings MC, Winterford CM and Walker NI: Apoptosis. Am J Surg Pathol 21: 88-101, 1997.
8. Von Boehmer H: Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol 8: 531-556, 1990.
9. Surh CD and Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103, 1994.
10. Rudel T: Caspase inhibitors in prevention of apoptosis. Herz 24: 236-241, 1999.
11. Hockenbery D, Nunez G, Milligan C, Schreiber RD and Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 333-336, 1990.
12. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M and Viale G: The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to estrogen receptor status. Virchows Archiv 424: 47-51, 1994.
13. Onodera J, Nakamura N, Nagano I, Tobita M, Yoshioka M, Takeda A, Oouchi M and Itoyama Y: Up-regulation of Bcl-2 protein in the myasthenic thymus. Ann Neurol 39: 521-528, 1996.
14. Salakou S, Tsamandas AC, Bonikos D, Papapetropoulos T and Dougenis D: The potential role of bcl-2, bax and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters. Eur J Cardiothoracic Sur 20: 712-721, 2001.
15. Oltvai Z, Milliman C and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conversed homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
16. Yang E and Korsmeyer S: Molecular thanatopics: a discourse on the BCL2 family and cell death. Blood 88: 386-401, 1996.
17. Korsmeyer SJ: Bcl-2 gene family and the regulation of programmed cell death. Cancer Res 59: S1693-S1700, 1999.
18. Scopa CD, Vagianos C, Kardamakis D, Kourelis T, Kalofonos H and Tsamandas AC: bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. App Immunohistochem Mol Morph 9: 329-334, 2001.
19. Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, Skill NJ, Haylor JL and El Nahas AM: Expression of apoptosis related genes and proteins in experimental chronic renal scarring. J Amer Soc Nephrol 12: 275-288, 2001.
20. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K and Hardwick JM: Conversion of bcl-2 to a bax like death effector by caspases. Science 278: 1966-1968, 1997.
21. Rosai J: Thymus. In: Rosai and Ackerman's Surgical Pathology. Rosai J (ed.). New York, Mosby, pp. 462-483, 2004.
22. Dadmanesh F, Sekihara T and Rosai J: Histologic typing of thymoma according to the New World Health Organization classification. Chest Surgery Clinics North America 11: 407-420, 2001.
23. Jaretzki A, Barohn RB, Ernstoff R, Kaminski HR, Keesey JC, Penn AS and Sanders DB: Myasthenia gravis: recommendation for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55: 16-23, 2000.
24. Tilly JL, Tilly KI, Kenton ML and Johnson AL: Expression of members of the bcl-2 family in the immature rat ovary: Equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis with decreased Bax and constitutive Bcl-2 and Bcl-xlong messenger ribonucleic acid levels. Endocrinology 136: 232-241, 1995.
25. Kornstein MJ, Brooks JJ, Anderson AO, Levinson AI, Lisak RP and Zweiman B: The immunohistology of the thymus in myasthenia gravis. Am J Pathol 117: 184-194, 1984.
26. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R and Reed JC: Immunohistochemical analysis of in vivo patterns of expression of CPP32(caspase-3), a cell death protease. Cancer Res 57: 1605-1613, 1997.
27. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA and Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403: 98-103, 2000.
28. Yang B, El Nahas AM, Thomas GL, Haylor JL, Watson PF, Wagner B and Johnson TS: Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney Int 60: 1765-1776, 2001.
29. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA and Hardwick JM: Caspase-3-dependent cleavage of bcl-2 promotes release of cytochrome c. J Biol Chem 274: 21155-21161, 1999.